# Celldex Therapeutics, Inc.: Form DEF 14A, filed Apr 30, 2018

- Company: [Celldex Therapeutics, Inc.](/companies/cldx.md) (CIK 744218)
- Form: DEF 14A
- Filed: 2018-04-30
- Accepted by EDGAR: Apr 30, 2018, 09:00 ET
- Period: 2018-06-13
- Accession: 0001047469-18-003326
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/744218/000104746918003326/a2235493zdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/744218/000104746918003326/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/744218/000104746918003326/a2235493zdef14a.htm

Filed Apr 30, 2018.
Source: SEC EDGAR, the filing index for accession 0001047469-18-003326. Last ingested by Listed: Nov 5, 2026, 19:04 ET. No prices; not investment advice.
